Tumor immunologic aspects of lung cancer treatment
Nilsson, B.
Lakartidningen 76(20): 1933-1934
1979
ISSN/ISBN: 0023-7205 PMID: 449470 Document Number: 147603
Document emailed within 1 workday
Related Documents
Reed, C.E.; deShazo, R. 1982: Immunologic aspects of granulomatous and interstitial lung diseases JAMA 248(20): 2683-2691Trakhtenberg, A.K.; Kharchenko, V.P.; Glagolev, A.N.; Kuz'min, I.V.; Zakharchenkov, A.V. 1978: Various aspects of surgical treatment of lung cancer Khirurgiia 11: 92-98
Otani, Y.; Kondo, T.; Saito, R.; Matsumura, Y.; Ohura, H.; Hirose, M.; Horikoshi, A.; Sado, T.; Sugita, M.; Okaniwa, G. 1995: Surgical treatment of metastatic lung tumor from colorectal cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 48(9): 735-740
Kuzin, M.I.; Adamian, A.A.; Bagaudinov, K.G. 1980: Clinical aspects and surgical treatment of lung cancer in the middle-aged and elderly Grudnaia Khirurgiia 4: 51-55
Holmes, E.C.; Golub, S.H. 1976: Immunologic defects in lung cancer patients Journal of Thoracic and Cardiovascular Surgery 71(2): 161-168
Drukin, E.I.; Karaseva, N.A. 1985: Histological structure and tumor size as prognostic factors in the surgical treatment of patients with peripheral lung cancer Vestnik Khirurgii Imeni I. I. Grekova 135(9): 14-17
Nagai, M.; Oguma, H.; Arai, F.; Watanabe, E.; Nakazawa, M. 2014: Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer No Shinkei Geka. Neurological Surgery 42(4): 327-334
Asamura, H. 1997: State of the art treatment of lung cancer: non-small cell lung cancer--surgical treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 366-372
De Escalante Yangüela, B.; Tres Sánchez, A.; Sampedro Feliu, J.A.; Ruiz Laiglesia, F.; Zabala López, S.; Larrad Mur, L. 1992: Effect of age, nutritional status and tumor extension on various immunologic parameters in cancer patients Anales de Medicina Interna 9(1): 14-20
Yang, B.; Zheng, D.; Zeng, Υa.; Qin, A.; Gao, J.; Yu, G. 2018: Circulating tumor cells predict prognosis following secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell lung cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(4): 1077-1081
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
Hijmering-Kappelle, L.B.M.; van der Wekken, A.J.; Hiltermann, T.J.N.; Groen, H.J.M. 2017: New biopsy at lung cancer progression: rational treatment of resistant lung cancer Nederlands Tijdschrift Voor Geneeskunde 161: D1229
Provotorov, V.M.; Nikitin, A.V.; Petrov, A.V. 1985: Clinico-immunologic aspects of the differentiated use of plasma substitutes in the complex treatment of various bronchopulmonary diseases Terapevticheskii Arkhiv 57(10): 89-94
Zeller, F. 1989: Immunologic cancer treatment Deutsche Medizinische Wochenschrift 114(19): 771
Kimura, I.; Ohnoshi, T.; Nakata, Y.; Nakata, Y.; Hiraki, S.; Miyake, K. 1980: Lung cancer: problems in the treatment of advanced lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 18(9): 572-577
Beard, D.B.; Haskell, C.M. 1986: Pharmacologic aspects of lung cancer chemotherapy Clinics in Chest Medicine 7(3): 505-513
Miller, F.R.; Heppner, G.H. 1979: Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor Journal of the National Cancer Institute 63(6): 1457-1463
Harris, D.T.; Matyas, G.R.; Gomella, L.G.; Talor, E.; Winship, M.D.; Spitler, L.E.; Mastrangelo, M.J. 1999: Immunologic approaches to the treatment of prostate cancer Seminars in Oncology 26(4): 439-447
Oremek, G.; Kukshaĭte, R.; Sapoutzis, N.; Ziolkowski, P. 2007: The significance of TU M2-PK tumor marker for lung cancer diagnostics Klinicheskaia Meditsina 85(7): 56-58
Camplese, P.; Sacco, R. 2004: Pneumonectomy for lung cancer: technical and general aspects Rays 29(4): 413-417